Profile for Sorrento Therapeutics Inc. (SRNE)

$ 5.17   -0.10 (-1.90%) Volume: 27.76m 4:00 PM EDT May 27, 2020
After Hours:  $ 5.1401   -0.0299 (-0.58%) Volume: 419.72k 7:59 PM EDT May 27, 2020
Business Description:
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases.
Address: 4955 Directors Place, San Diego, CA, USA, 92121
Telephone: +1 858 203-4100 Website: https://www.sorrentotherapeutics.com
Facsimile: +1 858 203-4028 Email: [email protected]
Details
CEO: Henry Ji
Employees: 310 Market Cap: 1.08b
Issue Type: CS
Auditor: Deloitte & Touche LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 850261
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Commercial Physical And Biological Research (8731)